AI brief of an SEC Form 8-K · World Kinect (WKC)

World Kinect extends $2 billion credit facility to November 2030 with lower pricing

Neutral Impact 3 of 5 financing Written later

World Kinect amended its credit agreement on November 10, 2025, raising the revolving commitments from $1.50 billion to $1.65 billion and extending maturity from April 1, 2027 to November 10, 2030. The total borrowing capacity stays at $2.0 billion, and pricing and commitment fees were lowered, which the filing describes as improved terms and greater operating flexibility for shareholders to weigh alongside the company's other obligations.

Key points

  • Revolving commitments increased from $1.50 billion to $1.65 billion; new term loan of $350 million replaces the $500 million Original Term Loan
  • Maturity extended from April 1, 2027 to November 10, 2030, with a one-time one-year extension option
  • Commitment fees lowered to a range of 0.225% to 0.300%, from 0.225% to 0.375%, depending on leverage ratio
  • Approximately $93 million of cash on hand was used together with the new term loan to repay the Original Term Loan and pay fees

The filing

CompanyWorld Kinect (WKC)
Form8-K, current report
Filed with the SECNov 13, 2025, 5:15 PM ET
Accession number0001193125-25-280505

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 13, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.